The Biden administration on Oct. 21 issued a new proposed rule that would require health insurance providers to cover an ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

In a groundbreaking development for HIV prevention, the efficacy and safety of a six-monthly injection containing the antiretroviral drug lenacapavir have been confirmed through two pivotal studies.

Explore HIV prevention options for women, including dapivirine rings and dual prevention pills, aiming to reduce infections ...

This year has seen a double dose of optimism in the field of HIV prevention. First, on 20 June 2024, came the results of the Purpose-1 trial in South Africa and Uganda.1 This randomised controlled ...

The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...

Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...

Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...

But the growing range of HIV prevention options has failed to translate into more ... which reduces one’s risk of getting ...

In June, we heard what could be this year’s biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. A ...